<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04399941</url>
  </required_header>
  <id_info>
    <org_study_id>H-37396</org_study_id>
    <nct_id>NCT04399941</nct_id>
  </id_info>
  <brief_title>Intravascular Ultrasound in Patients With End-stage Renal Disease on Dialysis</brief_title>
  <acronym>IVUS in ESRD</acronym>
  <official_title>Role of Intravascular Ultrasound in Patients With End-stage Renal Disease on Dialysis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hemodialysis represents a life line of patients with end stage renal disease, who are
      commonly maintained on hemodialysis through catheters. Prolonged exposure to these catheters
      eventually damages the walls of veins, which results in stenosis at the local site. This
      condition is called central venous stenosis (CVS) and affects number of patients on
      hemodialysis in the United States and can compromise the dialysis efficacy. The current
      diagnostic modality for CVS is venography, which has several limitations. This study proposes
      to examine intravenous ultrasound (IVUS) as a potentially superior modality, which will
      provide additional information.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 2020</start_date>
  <completion_date type="Anticipated">September 2022</completion_date>
  <primary_completion_date type="Anticipated">September 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Extent of stenosis</measure>
    <time_frame>18 months</time_frame>
    <description>The severity of venous stenosis will be assessed using venogram and IVUS results. It will be calculated as the percentage diameter or area reduction, expressed as the ratio of the MLD or MLA to the RVD or RVA.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Length of lesions</measure>
    <time_frame>18 months</time_frame>
    <description>The length of each lesion will be measured between points with &gt;50% diameter reduction in comparison to the referenced vein diameter and the referenced vein area at the pre-stenotic venous segment.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Morphology of lesion</measure>
    <time_frame>18 months</time_frame>
    <description>The morphology of lesion will be defined as fibrotic and fibrofatty based on IVUS images.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>End Stage Renal Disease</condition>
  <arm_group>
    <arm_group_label>IVUS and venography group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in the this group will receive venography/fistulogram, intravascular ultrasound (IVUS), and image processing.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Venography</intervention_name>
    <description>The venography will be performed as part of the patient's standard of care. The dialysis access will be punctured upstream of the arteriovenous anastomosis in AVF or AVG using a 4-F coaxial access set (Micro- puncture; Cook, Inc, Bloomington, Indiana). The contrast will be injected intravenously by a pump with 200 psi and a bolus of 2m/sec for total of 5 ml during upper extremity vein filming and 10 ml of contrast bolus by 3 ml/s during central vein filming while holding the breath in inspiration in anterioposterior plane.</description>
    <arm_group_label>IVUS and venography group</arm_group_label>
    <other_name>Fistulogram</other_name>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Intravascular ultrasound (IVUS)</intervention_name>
    <description>IVUS will be performed through the same sheath of the coaxial access set using an Eagle Eye Platinum RX digital catheter 7F over a compatible guidewire under fluoroscopic guidance. The lesion will be estimated fluoroscopically from the marker IVUS catheter in the vein and the cranial and caudal margins of stenotic lesion will be directly visualized during pullback of the IVUS catheter.</description>
    <arm_group_label>IVUS and venography group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Image processing</intervention_name>
    <description>Image processing will be performed by two radiologists in a blinded manner on the images devoid of personal identifier. An adjudication committee will oversee the process and confirm their findings in case of a discrepancy.</description>
    <arm_group_label>IVUS and venography group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ESRD (end stage renal disease) patients at BMC (Boston Medical Center)

          -  Receiving hemodialysis

          -  Has a dialysis access malfunction

          -  Undergoing a diagnostic fistulogram for the dialysis access malfunction

        Exclusion Criteria:

          -  None
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vipul Chitalia, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Boston Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Vipul Chitalia, MD PhD</last_name>
    <phone>617 638 7330</phone>
    <email>vipul.chitalia@bmc.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Boston Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02118</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Vipul Chitalia, MD PhD</last_name>
      <email>vipul.chitalia@bmc.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 19, 2020</study_first_submitted>
  <study_first_submitted_qc>May 21, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 22, 2020</study_first_posted>
  <last_update_submitted>May 21, 2020</last_update_submitted>
  <last_update_submitted_qc>May 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>intravenous ultrasound (IVUS)</keyword>
  <keyword>central venous stenosis (CVS)</keyword>
  <keyword>hemodialysis</keyword>
  <keyword>dialysis access malfunction</keyword>
  <keyword>fistulogram</keyword>
  <keyword>stenosis</keyword>
  <keyword>virtual histology (VH-IVUS) software</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Kidney Failure, Chronic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

